Featured Trends
We’ve sliced and diced our portfolio into distinct “trends” that define our edge.
Climate 100
We are pleased to report that as of April 2021 the SOSV Climate Tech 100 have raised $1.85 billion from investors and have a market cap of $5.65 billion. The average company is four years old. SOSV (our parent fund) has invested $89 million in these companies and was in most cases the first investor, though we continued investing through early rounds.
IndieBio has never been one to shy away from the riskiest and most impactful investments for our planet. In fact, we embrace them.
Female Founder
Boosting female representation in the startup world is an ongoing challenge, but we’re dedicated to gender balance, not only because it’s the right thing to do, but because we would be dismissing impressive companies otherwise. We’ve found that more gender balance leads to better workplace culture and better ideas being exchanged.
Future of Food
It’s not just that we can make meat and fish in the lab, or with mushrooms and chickpeas. It’s not just that AI can predict the best plant ingredients to make the best tasting milk and yogurt. And it’s not just that yeast can be fermented to produce the healthier and better food preservatives. We’re diving deep every day into the foods that will satisfy novelty-seekers and conventionalists alike.
We’re putting big bets on the newest technologies and trends we think are ahead of the curve.
Future of Medicine
Medicine ain’t what it used to be. Today, bloodletting, skull-drilling and giving children cocaine for toothaches are relics of the past. Tomorrow, so too will addictive opioids, chemotherapy, and psychiatric drugs that are non-selectively bathing our bodies in chemicals.
The future of medicine is an exciting one, and we’re excited to share the most exciting technologies that enable the next wave of medicine and healthcare.
Impact
Our mission has always been Human and Planetary Health from the beginning, so it’s hard to say which of our companies are “impact” companies (in some ways, they all are).
Here, we narrowed down the startups that are directly addressing sustainability issues, improving public health, mitigating inequality, and democratizing access to infrastructure and technologies.
New Frontiers
Raising Now
Every season of the year, a new batch and about one-sixth of our alumni are in raise mode. These companies are currently raising and would love to talk to interested investors. We can set up those meetings or you can contact the companies directly.
Sustainable Solutions
Every year, pests destroy 20% to 40% of global crop yields despite widespread use of synthetic pesticides. We spend $100 billion per year on chemicals that perform poorly, kill pollinators, and have been correlated with cancer, endocrine disruption, and brain damage in human beings. Farmers will need better solutions to feed 9.7 billion people in […]
The $500 billion personal care and cosmetics industry is alarmingly reliant on raw materials from livestock. The three most important proteins in skincare and haircare products—collagen, keratin, and elastin—typically come from bovine hides, chicken feathers, and meat processing byproducts, respectively. Thus, cosmetics contribute to greenhouse gas emissions, water pollution, and deforestation. With two-thirds of consumers […]
For centuries, chocolate has been a staple ingredient and sweet treat in diets all over the world, but its future is in trouble. Chocolate production has long been associated with significant carbon emissions and deforestation, with a looming supply deficit predicted by 2030. To save chocolate, Nukoko is transforming the industry with its sustainable and […]
In discussions surrounding climate change, there is often a focus on the negative impacts of high carbon levels in the atmosphere. However, it’s important to recognize that carbon itself is not our adversary. Instead, CroBio is leading the charge against years of unsustainable practices by restoring the balance of carbon between the soil and the […]
A new wave of RNA therapeutics has the potential to transform treatment for solid tumours. Existing non-viral technologies cannot target tumour cells. Moreover, these fail to release the therapeutic RNA into the cytosol, less than 1% leaks out of the endosomes (a sub-cellular compartment). The remaining 99% is degraded. EndoPore is Vitarka Therapeutics’ solution to […]
During the last century, an oil economy fueled advances in chemistry creating drugs, industrial materials, food, and energy. This century is looking to the bioeconomy and engineering biology to provide more sustainable alternatives to heal, feed and fuel us. Based on groundbreaking decarbonization research at Imperial College, CyclicBio has engineered microorganisms called cyanobacteria to convert […]
Alternatives to animal protein include plant-based, fermentation-based, and cellular agriculture-based options, but all suffer from a lack of true ‘meatiness.’ Kyomei is using a novel strategy to scale production of meat myoglobin produced in plants. Their patented ingredient will be the foundation of truly satisfying umami plant-based burgers, powering the next generation of tasty plant-based […]
Pannex Therapeutics is a pioneer biopharmaceutical company totally focused on the development of a novel therapeutic class of Pannexin 1 channel (Panx1) blockers. Pannex is developing a platform of small molecules that blocks this exciting new pharmacological target, Panx1 channels. With potential applications in many therapeutic areas, the initial focus is on chronic pain treatment. […]
The cosmetic effects of ageing on skin and the development of skin cancers result from multiple changes in three types of skin cells (fibroblasts, keratinocytes, melanocytes) and degeneration of extracellular components (collagen, elastin). These changes are accelerated by toxic chemicals that are produced in skin when it is exposed to all wavelengths of sunlight, all […]
Solving the sustainability problems of silk.